TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 187,359 | 174,842 | 187,919 |
Financial expenses | 1,074 | 606 | 384 |
Earnings before taxes | 7,583 | 7,486 | 8,391 |
EBITDA | 28,044 | 31,354 | 38,369 |
Total assets | 126,621 | 174,628 | 172,477 |
Current assets | 39,986 | 73,824 | 56,701 |
Current liabilities | 32,278 | 26,416 | 26,885 |
Equity capital | 91,711 | 93,185 | 88,851 |
- share capital | 2,247 | 2,445 | 2,491 |
Employees (average) | 984 | 882 | 888 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 72.4% | 53.4% | 51.5% |
Turnover per employee | 190 | 198 | 212 |
Profit as a percentage of turnover | 4.0% | 4.3% | 4.5% |
Return on assets (ROA) | 6.8% | 4.6% | 5.1% |
Current ratio | 123.9% | 279.5% | 210.9% |
Return on equity (ROE) | 8.3% | 8.0% | 9.4% |
Change turnover | 26,679 | -9,597 | -8,005 |
Change turnover % | 17% | -5% | -4% |
Chg. No. of employees | 102 | -6 | 54 |
Chg. No. of employees % | 12% | -1% | 6% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.